ArticleRand health quarterly2026

Advancing Development of LRRK2-Targeted Therapeutics for Parkinson's Disease: Conference Proceedings and Roadmap for Research.

Zachary Predmore et al.PubMed ↗Full text ↗

No numbers read from the abstract.